- Report
- May 2024
- 133 Pages
Global
From €6071EUR$6,499USD£5,136GBP
- Report
- June 2024
- 200 Pages
Global
From €7427EUR$7,950USD£6,283GBP
- Report
- January 2022
- 60 Pages
Global
From €3690EUR$3,950USD£3,122GBP
Oncocytoma drugs are a type of oncology drug used to treat tumors that originate from cells called oncocytes. These drugs are typically used to treat tumors in the kidney, bladder, and thyroid, and can be administered orally, intravenously, or through injection. Oncocytoma drugs work by targeting the cancer cells and preventing them from growing and spreading. Common side effects of oncocytoma drugs include nausea, vomiting, fatigue, and hair loss.
The oncocytoma drug market is highly competitive, with many companies offering a variety of treatments. Companies such as Novartis, Pfizer, and Merck are some of the major players in the market, offering a range of oncocytoma drugs. Other companies such as AstraZeneca, Bristol-Myers Squibb, and Eli Lilly also offer oncocytoma drugs. Show Less Read more